Eli Lilly (LLY 0.76%) and Novo Nordisk (NVO 1.59%) benefit from innovative treatments for obesity and diabetes.
*Stock prices used were the afternoon prices of Jan. 5, 2025. The video was published on Jan. 7, 2025.

Eli Lilly (LLY 0.76%) and Novo Nordisk (NVO 1.59%) benefit from innovative treatments for obesity and diabetes.
*Stock prices used were the afternoon prices of Jan. 5, 2025. The video was published on Jan. 7, 2025.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.